Biogen Inc (BIIB-Q) Analyst Research & Price Targets - The Globe and Mail

Earnings Estimates

	Current Qtr06/2026	Next Qtr09/2026	Fiscal Yr12/2026	Fiscal Yr12/2027
Average Estimate	$3.36	$3.90	$13.89	$16.22
Number of Estimates	21	13	14	17
High Estimate	$4.40	$4.66	$15.90	$19.35
Low Estimate	$2.33	$3.20	$10.09	$10.78
Prior Year	$5.47	$4.81	$15.28	$13.89
Growth Rate Est. (year over year)	-38.57%	-18.92%	-9.10%	+16.77%

Earnings History - Surprises*

	Qtr Ending03/2026	Qtr Ending12/2025	Qtr Ending09/2025	Qtr Ending06/2025
Reported	$3.57	$1.99	$4.81	$5.47
Estimate	$2.95	$1.61	$3.89	$3.93
Difference	+0.62	+0.38	+0.92	+1.54
Surprise	+21.02%	+23.60%	+23.65%	+39.19%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

3.83

3 Mths Ago35

3.85

2 Mths Ago34

4.06

1 Mth Ago35

4.09

Current35

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	35	34	35	35
	14 1	14 1	18 1	18 2
Holds	20	19	16	15

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

Thursday’s analyst upgrades and downgrades

Wednesday’s analyst upgrades and downgrades

number cruncher

Seven Canadian small-cap stocks with cheap valuations

Bullish on Freeport-McMoRan Inc.

Gildan shares sink 19 per cent on short seller report alleging inflated sales

The highest-yielding stocks on the TSX, plus risk data

The most oversold and overbought stocks on the TSX

Insider Report: Co-chair buys the dip investing over US$1-million in this beaten-down stock